Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.79 | N/A |
| PEG Ratio (TTM) | -0.55 | N/A |
| P/S Ratio (TTM) | 3.24 | N/A |
| P/B Ratio (TTM) | 1.47 | N/A |
| P/FCF Ratio (TTM) | 6.19 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.76 | N/A |
| Price to 5YR AVG FCF Ratio | -11.79 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.63% | N/A |
| ROE (TTM) | 11.09% | N/A |
| Net Profit Margin (TTM) | 25.33% | N/A |
| ROIC 5YR AVG | 7.17% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -10.19% | 627.32% | 372.31% |
| Revenue | -0.93% | 67.10% | 41.85% |
| Net Income | -10.06% | 631.04% | 374.58% |
| Cash Flow | 6.22% | 86.06% | 48.02% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.21 | N/A |
| Quick Ratio (TTM) | 2.18 | N/A |
| D/E Ratio (TTM) | 0.94 | N/A |
| Interest Coverage (TTM) | 1.91 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 0.72 | N/A |
| LTL to 5YR AVG FCF | -17.14 | N/A |
| Shares Outstanding Growth 5YR AVG | 6.60% | N/A |